Observing metabolic differences in thyroid cancer patients before radioiodine treatment
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
This study is trying to see how two different ways of preparing thyroid cancer patients for radioiodine treatment affect their metabolism.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Taichung Veterans General Hospital Academic / other |
| Locations | 1 site (Taichung) |
| Trial ID | NCT03624751 on ClinicalTrials.gov |
What this trial studies
This observational study aims to compare the metabolic profiles of thyroid cancer patients who choose between Thyrogen® injection and Eltroxin® withdrawal prior to undergoing radioiodine therapy or scans. A total of 500 patients will be enrolled, and blood and urine samples will be collected at three visits to analyze lipid profiles, glucose levels, and inflammation markers. The goal is to determine how these two preparation methods affect metabolic outcomes in patients with thyroid cancer.
Who should consider this trial
Good fit: Ideal candidates are patients diagnosed with thyroid cancer who require radioiodine therapy or scans.
Not a fit: Patients who are unable to cooperate with blood tests or radioiodine therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help optimize pre-treatment protocols for thyroid cancer patients, leading to better health outcomes.
How similar studies have performed: While there is ongoing research in thyroid cancer treatment protocols, this specific comparison of Thyrogen® injection versus Eltroxin® withdrawal is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with diagnosis of thyroid cancer。 2. Patients who need radioiodine therapy or scan。 Exclusion Criteria: 1. Patients cannot cooperate with blood test.。 2. Patients cannot cooperate with radioiodine therapy。
Where this trial is running
Taichung
- Division of Endocrinology and Metabolism in Taichung Veterans General Hospital — Taichung, Taiwan (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.